{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:38:10Z","timestamp":1794062290453,"version":"4.8.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Patients with endogenous Cushing's syndrome (CS) have elevated mortality, particularly during active disease. A recent meta-analysis reported reduced mortality rates after 2000 in adrenal CS and Cushing disease (CD), though many studies lacked population-matched controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Nationwide retrospective study (2000-2023) in Israel using the Clalit Health Services database to assess all-cause mortality in patients with endogenous CS matched 1:5 with controls by age, sex, socioeconomic-status, and body mass index (BMI). Primary outcome was all-cause mortality. Secondary outcomes included cause-specific mortality, impact of hypercortisolism remission, disease source, and mortality risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The cohort included 609 cases with CS (mean age 48.1 \u00b1 17.2 years; 65.0% women) and 3018 matched controls (47.9 \u00b1 17.2 years; 65.4% women). Over a median follow-up of 16 years, 133 cases (21.8%) and 472 controls (15.6%) died (HR = 1.44, 95% CI, 1.19-1.75). Both patients with CD (HR = 1.73, 95% CI, 1.27-2.36) and adrenal CS (HR = 1.31, 95% CI, 1.00-1.81) had increased mortality risk. Patients without remission within 2 years had a higher mortality risk than those achieving remission (HR = 1.44, 95% CI, 1.00-2.17). Mortality was similar for CD and adrenal CS (HR = .83, 95% CI, .56-1.24). Older age, male gender, and prior malignancy were independent risk factors for mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the largest national cohort study on mortality risk in CS over the past 2 decades, showing a significantly higher risk compared to matched controls in a homogeneous database. While etiology had no impact, remission significantly affected mortality, highlighting the importance of disease control for long-term survival.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf059","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T20:29:08Z","timestamp":1743625748000},"page":"445-455","source":"Crossref","is-referenced-by-count":18,"title":["Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva 49100 ,","place":["Israel"]},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[{"name":"Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health & Science University , Portland, OR 97239 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8025","authenticated-orcid":false,"given":"Hiba","family":"Masri-Iraqi","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva 49100 ,","place":["Israel"]},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-8327","authenticated-orcid":false,"given":"Tzipora","family":"Shochat","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Rabin Medical Center, Beilinson Hospital , Petah Tikva 49100 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5249","authenticated-orcid":false,"given":"Shiri","family":"Kushnir","sequence":"additional","affiliation":[{"name":"Research Authority, Rabin Medical Center, Beilinson Hospital , Petah Tikva 49100 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva 49100 ,","place":["Israel"]},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva 49100 ,","place":["Israel"]},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"2","key":"2025043004213891500_lvaf059-B1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"10418","key":"2025043004213891500_lvaf059-B2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"2025043004213891500_lvaf059-B3","doi-asserted-by":"publisher","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing's syndrome: update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2025043004213891500_lvaf059-B4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025043004213891500_lvaf059-B5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2025043004213891500_lvaf059-B6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025043004213891500_lvaf059-B7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in stoke-on-trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2025043004213891500_lvaf059-B8","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2025043004213891500_lvaf059-B9","doi-asserted-by":"publisher","first-page":"E2035","DOI":"10.1210\/clinem\/dgab058","article-title":"Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality","volume":"106","author":"Schernthaner-Reiter","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2025043004213891500_lvaf059-B10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11102-023-01343-2","article-title":"Complications and mortality of Cushing's disease: report on data collected over a 20-year period at a referral centre","volume":"26","author":"Mondin","year":"2023","journal-title":"Pituitary"},{"issue":"5","key":"2025043004213891500_lvaf059-B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025043004213891500_lvaf059-B12","doi-asserted-by":"publisher","first-page":"101521","DOI":"10.1016\/j.beem.2021.101521","article-title":"Epidemiology and mortality of Cushing's syndrome","volume":"35","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2025043004213891500_lvaf059-B13","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac045","article-title":"Increased mortality persists after treatment of Cushing's disease: a matched nationwide cohort study","volume":"6","author":"Bengtsson","year":"2022","journal-title":"J Endocr Soc"},{"issue":"9","key":"2025043004213891500_lvaf059-B14","doi-asserted-by":"publisher","first-page":"e240028","DOI":"10.1530\/ERC-24-0028","article-title":"Insights on epidemiology, morbidity and mortality of Cushing's disease in Northern Ireland","volume":"31","author":"Loughrey","year":"2024","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2025043004213891500_lvaf059-B15","doi-asserted-by":"publisher","first-page":"e13113","DOI":"10.1111\/jne.13113","article-title":"Long-term morbidity and mortality in patients with Cushing's syndrome","volume":"34","author":"Braun","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2025043004213891500_lvaf059-B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ejendo\/lvae069","article-title":"Long-term outcomes in patients with Cushing's disease vs nonfunctioning pituitary adenoma after pituitary surgery: an active-comparator cohort study","volume":"191","author":"Germann","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025043004213891500_lvaf059-B17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ecl.2018.02.005","article-title":"Mortality in patients with endogenous Cushing's syndrome","volume":"47","author":"Javanmard","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2025043004213891500_lvaf059-B18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025043004213891500_lvaf059-B19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025043004213891500_lvaf059-B20","doi-asserted-by":"publisher","first-page":"E1362","DOI":"10.1210\/clinem\/dgaa752","article-title":"Epidemiology and comorbidity of adrenal Cushing syndrome: a nationwide cohort study","volume":"106","author":"Ahn","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025043004213891500_lvaf059-B21","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2025043004213891500_lvaf059-B22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ejendo\/lvae098","article-title":"Endogenous Cushing's syndrome and cancer risk","volume":"191","author":"Rudman","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025043004213891500_lvaf059-B23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11102-024-01399-8","article-title":"Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with Cushing's syndrome: a large population database study","volume":"27","author":"Dery","year":"2024","journal-title":"Pituitary"},{"issue":"4","key":"2025043004213891500_lvaf059-B24","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1210\/clinem\/dgae337","article-title":"Biochemical control in Cushing's syndrome: outcomes of the treatment in a large single center cohort","volume":"110","author":"Ritzel","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025043004213891500_lvaf059-B25","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"2025043004213891500_lvaf059-B26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"6","key":"2025043004213891500_lvaf059-B27","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2025043004213891500_lvaf059-B28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2174\/0113816128290025240216110928","article-title":"Current and emerging pharmacological therapies for Cushing's disease","volume":"30","author":"Divaris","year":"2024","journal-title":"Curr Pharm Des"},{"issue":"04","key":"2025043004213891500_lvaf059-B29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/a-0580-0460","article-title":"Cushing's syndrome: a historic review of the treatment strategies and corresponding outcomes in a single tertiary center over the past half-century","volume":"50","author":"Nankova","year":"2018","journal-title":"Horm Metab Res"},{"issue":"4","key":"2025043004213891500_lvaf059-B30","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis","volume":"172","author":"Van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025043004213891500_lvaf059-B31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025043004213891500_lvaf059-B32","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","article-title":"Long-term consequences of Cushing syndrome: a systematic literature review","volume":"109","author":"Puglisi","year":"2024","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2025043004213891500_lvaf059-B33","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1530\/EJE-20-1309","article-title":"Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach","volume":"184","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025043004213891500_lvaf059-B34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s11102-022-01261-9","article-title":"Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols","volume":"25","author":"Feelders","year":"2022","journal-title":"Pituitary"},{"issue":"1","key":"2025043004213891500_lvaf059-B35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ejendo\/lvad176","article-title":"High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery","volume":"190","author":"Isand","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025043004213891500_lvaf059-B36","doi-asserted-by":"publisher","first-page":"e240046","DOI":"10.1530\/EC-24-0046","article-title":"Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey","volume":"13","author":"Cherenko","year":"2024","journal-title":"Endocr Connect"},{"key":"2025043004213891500_lvaf059-B37","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02486-0","article-title":"Unusual infections and thrombotic events in Cushing's syndrome","author":"Barbot","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"10444","key":"2025043004213891500_lvaf059-B38","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","article-title":"Hypopituitarism","volume":"403","author":"Fleseriu","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"2025043004213891500_lvaf059-B39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2025043004213891500_lvaf059-B40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/ejendo\/lvad008","article-title":"Cushing's syndrome in the elderly: data from the European registry on Cushing's syndrome","volume":"188","author":"Amodru","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025043004213891500_lvaf059-B41","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025043004213891500_lvaf059-B42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fendo.2019.00580","article-title":"Sex differences in presentation but not in outcome for ACTH-dependent Cushing's syndrome","volume":"10","author":"Broersen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025043004213891500_lvaf059-B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae405","article-title":"Cushing syndrome is associated with a higher risk of cancer\u2014a nationwide cohort study","author":"Wu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2025043004213891500_lvaf059-B44","doi-asserted-by":"publisher","first-page":"1161768","DOI":"10.3389\/fendo.2023.1161768","article-title":"Glucocorticoid regulation of cancer development and progression","volume":"14","author":"Khadka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9612","key":"2025043004213891500_lvaf059-B45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"2025043004213891500_lvaf059-B46","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"2025043004213891500_lvaf059-B47","doi-asserted-by":"publisher","first-page":"e1424","DOI":"10.1210\/clinem\/dgae151","article-title":"Epigenetic mechanisms modulated by glucocorticoids with a focus on Cushing syndrome","volume":"109","author":"Paes","year":"2024","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2025043004213891500_lvaf059-B48","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1210\/clinem\/dgaa774","article-title":"Diabetes, active disease, and afternoon Serum cortisol levels predict Cushing's disease mortality: a cohort study","volume":"106","author":"Rold\u00e1n-Sarmiento","year":"2021","journal-title":"J Clin Endocrinol Metab."}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf059\/62845179\/lvaf059.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/4\/445\/62845179\/lvaf059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/4\/445\/62845179\/lvaf059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:21:46Z","timestamp":1746001306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/4\/445\/8104169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf059","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,27]]}}}